Team

Phone: (203) 773-1195

David Scheer
Mr. Scheer is President of Scheer & Company, Inc., a firm founded in 1981, with activities in venture capital, corporate strategy, and transactional advisory services (corporate alliances, licensing arrangements, divestments, mergers, and acquisitions) exclusively in the life sciences. In venture capital, Mr. Scheer has been involved in the founding and has been a member of the Board of Directors of ViroPharma, Inc. (NASDAQ, “VPHM”), OraPharma, Inc. (acquired by Johnson & Johnson), Esperion Therapeutics, Inc. (of which he was Chairman, acquired by Pfizer), Sopherion Therapeutics, Inc (of which he was Chairman). His current portfolio of companies and directorships include Achillion Pharmaceuticals, Inc. (NASDAQ, “ACHN”), Tengion, Inc., Aegerion Pharmaceuticals, Inc., and Optherion, Inc. (the latter three of which he is serving as Chairman). From 1991 through 1999, he was affiliated with the health care investing team at Oak Investment Partners. He has served as a member of the Leadership Council of the Harvard School of Public Health, and a member of the Advisory Committee to the Harvard Malaria Initiative. Mr. Scheer is a Trustee of the Long Wharf Theatre, in New Haven, CT. He received his A.B. cum laude from Harvard College, and his M.S. from Yale University.

Amanda Hayward, Ph.D.
Dr. Hayward is the Senior Vice President of Scheer & Company, Inc. Dr. Hayward joined Scheer & Company in April 2000 as an Associate, was promoted to Vice President in 2002, and Senior Vice President in 2008. While at Scheer, Dr Hayward has been a leading member of engagement teams from Scheer providing corporate strategic advisory and consulting services to a broad range of clients, including both publicly- and privately-held companies. In addition, she has over seven years of company building experience, and played a significant role in the founding of Sopherion Therapeutics, Tengion, and Optherion, for each of which functioning as Acting CFO, and Aegerion. She has experience at a variety of levels including strategy, corporate development, fundraising, licensing, operations, recruiting, human resources, facilities and lease-line negotiations, and financial modeling. Prior to Scheer, she was a postdoctoral fellow at Yale University, where she held the Life Sciences Research Foundation Bristol Myers Squibb Fellowship. She currently serves as a Board member for The Friends of Yale New Haven Children’s Hospital, and as a Board Observer for Optherion. She received her B.S. (Hons) in Genetics from the University of Sheffield, England, and her Ph.D. in Cell Biology and Anatomy from Texas Tech University Health Sciences Center.

Home | Team | Contact